Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and one of the world’s leaders in oncology, is focused on harnessing the most compelling science with the aim of intercepting, preventing, treating, and ultimately curing cancer. Working toward t...
John W
JXSL1400038 人源抗CD38单克隆抗体(Daratumumab)注射液 治疗用生物制品 进口 2014-07-07 Janssen Research & Development, LLC 制证完毕-已发批件 2016-04-07 临床试验申请 查看 查看 JXSL1400045 人源抗CD38单克隆抗体(Daratumumab)注射液 治疗用生物制品 进口 2014-09-19 Janssen Research & Development, LLC...
05Talquetamab (Janssen Research & Development, LLC) Talquetamab是一款first-in-class现货型双特异性T细胞结合抗体,能同时靶向MM细胞上的GPRC5D和T细胞上的CD3,是继BCMA的Tecvayli之后,第二个用于多发性骨髓瘤的双特异性抗体。于2023年 8 月获 FDA 加速批准上市,其获批基于一项 I/II 期 MonumenTAL-1 临床试...
Research & Development. Creativity & Fresh Ideas. Science & Solutions. Collaboration is in our DNA. We know... Partner with Us We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine. ...
Kate Sasser, Ph. D. is Vice President, Oncology Translational Research, at Janssen Research & Development, LLC. She leads the translational research teams for the three oncology Disease Area Strongholds (DAS; lung, prostate and hematologic ... ...
Bayer’s development partner, Janssen Research & Development, LLC, has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for a new indication to expand the use of Xarelto (rivaroxaban) in people with peripheral artery disease (PAD) to include tho...
and projections of Janssen Research & Development, LLC, any of the other Janssen Pharmaceutical Companies, and/orJohnson & Johnson. Risks and uncertainties include, but are not limited to: challenges and uncertainties inherent in product research and development, including the uncertainty of clinical ...
and projections of Janssen Pharmaceutica NV, Janssen-Cilag Limited, Janssen Biotech, Inc., Janssen Research & Development, LLC, and/orJohnson & Johnson. Risks and uncertainties include, but are not limited to: challeng...
Janssen Research & Development, LLC. “Until now, advanced psoriasis treatments have been largely limited to injectable biologics. An oral therapy that can uniquely inhibit the IL-23 pathway by directly target...